Skip to main content
logo
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
3.070
+0.210 (7.34%)
At close: Nov 6, 2026, 4:00 PM EST
3.130
+0.060 (1.95%)
After-hours: Nov 6, 2026, 5:43 PM EST

CRBP Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.88
Revenue Growth
------77.61%
Cost of Revenue
90.2670.132.2231.1716.1436.45
Gross Profit
-90.26-70.1-32.22-31.17-16.14-35.56
Selling, General & Admin
16.6215.2216.513.9118.720.43
Operating Expenses
16.6215.2216.513.9118.720.43
Operating Income
-106.88-85.31-48.72-45.08-34.84-55.99
Interest Expense
---1.87-3.86-3.1-2.71
Interest & Investment Income
5.15.536.311.640.960.88
Currency Exchange Gain (Loss)
-----0.43-0.38
Other Non Operating Income (Expenses)
-1.230.140.072.70.0512.56
EBT Excluding Unusual Items
-103-79.64-44.21-44.6-37.35-45.64
Legal Settlements
-----5-
Other Unusual Items
1.11.14---
Pretax Income
-101.9-78.54-40.21-44.6-42.35-45.64
Net Income
-101.9-78.54-40.21-44.6-42.35-45.64
Net Income to Common
-101.9-78.54-40.21-44.6-42.35-45.64
Net Income Growth
------
Shares Outstanding (Basic)
171311444
Shares Outstanding (Diluted)
171311444
Shares Change
37.35%22.00%152.23%3.76%1.85%57.23%
EPS (Basic)
-6.09-5.90-3.68-10.31-10.15-11.15
EPS (Diluted)
-6.09-5.90-3.68-10.31-10.15-11.15
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-86.69-64.5-41.79-36.1-37.56-48.24
Free Cash Flow Per Share
-5.18-4.84-3.83-8.34-9.01-11.78
Operating Margin
------6350.09%
Profit Margin
------5176.38%
Free Cash Flow Margin
------5470.98%
EBITDA
-106.68-85.08-48.13-44.44-34.07-54.99
D&A For EBITDA
0.20.230.590.640.761
EBIT
-106.88-85.31-48.72-45.08-34.84-55.99
SEC Filings: 10-K · 10-Q